ARTICLE SUMMARY:
The current model for clinical trials is in need of reinvention; time is lost and quality is compromised in every step of a process that involves many stakeholders. ObvioHealth is a member of a new class of companies enabling virtual, decentralized clinical trials, which offer potential benefits around recruiting, adherence, retention, and speed to completion.
The COVID-19 pandemic has certainly highlighted the possibilities for technology to enable the remote delivery of healthcare, an opportunity not lost on companies developing remote platforms in aid of clinical trials.
